STOCK TITAN

Parian Ultreia reports 7.0% stake in Neuronetics (NASDAQ: STIM) — 4.84M shares

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Neuronetics, Inc. ownership filing: Parian Ultreia reports beneficial ownership of 4,844,908 shares, equal to 7.0% of the class, with sole voting and dispositive power over those shares. The filing is signed by Portfolio Manager Zachary Miller on 03/17/2026.

Positive

  • None.

Negative

  • None.

Insights

Passive investor discloses a 7.0% stake and sole control over 4,844,908 shares.

Parian Ultreia is recorded as beneficial owner of 4,844,908 shares with sole voting and dispositive power as of 03/17/2026. The Schedule 13G format signals a passive reporting position rather than an active activist intent.

Because the stake is 7.0%, below common control thresholds that often trigger additional governance actions, subsequent filings could clarify any change in intent; timing and cash‑flow treatment are not included in the excerpt.

Holder has clear single-party voting authority for a meaningful minority stake.

The filing lists sole voting and dispositive power for 4,844,908 shares, which concentrates decision rights in Parian Ultreia for that position. This establishes who can vote those shares at shareholder meetings.

Material governance effects depend on future actions; the filing itself is informational and does not state plans to nominate directors or engage in corporate actions.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



Parian Ultreia LP
Signature:Zachary Miller
Name/Title:Portfolio Manager
Date:03/17/2026

FAQ

What stake does Parian Ultreia report in Neuronetics (STIM)?

Parian Ultreia reports beneficial ownership of 4,844,908 shares, representing 7.0% of the class as disclosed in the Schedule 13G signed on 03/17/2026.

Does Parian Ultreia have voting control over its Neuronetics shares?

Yes. The filing states Parian Ultreia has sole voting power and sole dispositive power over all 4,844,908 shares, indicating unilateral authority to vote and direct disposals for that position.

Was the Schedule 13G filed as passive or active ownership?

The document is a Schedule 13G filing, which indicates a passive reporting position under the form type; it does not, in this excerpt, state any intention to influence control or nominate directors.

Who signed the filing on behalf of Parian Ultreia?

The Schedule 13G is signed by Zachary Miller, whose title is listed as Portfolio Manager, with the signature date shown as 03/17/2026.

Does the filing disclose whether proceeds or transactions are planned?

The excerpt does not include any statement about planned transactions or proceeds; it only reports current beneficial ownership, voting and dispositive powers as of the filing date.
Neuronetics

NASDAQ:STIM

View STIM Stock Overview

STIM Rankings

STIM Latest News

STIM Latest SEC Filings

STIM Stock Data

93.14M
33.96M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MALVERN